Insignia Financial Shares Hit 3-Year High Amid Bain and CC Capital Bidding War 
Mexico's Undervalued Equity Market Offers Long-Term Investment Potential 
Tech Stocks Rally in Asia-Pacific as Dollar Remains Resilient 
India–U.S. Interim Trade Pact Cuts Auto Tariffs but Leaves Tesla Out 
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains 
Vietnam’s Trade Surplus With US Jumps as Exports Surge and China Imports Hit Record 
South Korea to End Short-Selling Ban as Financial Market Uncertainty Persists 
China Extends Gold Buying Streak as Reserves Surge Despite Volatile Prices 
Bitcoin Hits $100K Milestone Amid Optimism Over Trump Policies 
Infosys Shares Drop Amid Earnings Quality Concerns 
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal 
How the UK’s rollback of banking regulations could risk another financial crisis 
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal 
Asian Stocks Slip as Tech Rout Deepens, Japan Steadies Ahead of Election 
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm 
China's Refining Industry Faces Major Shakeup Amid Challenges 
Investors value green labels — but not always for the right reasons 
While South Korean investors made Tesla a top pick among US-listed stocks with combined holdings of $9.7 billion as of Aug. 10, many had begun selling off shares in the world’s largest electric car maker in June while turning to vaccine-related stocks, including Moderna.
In June, South Korean investors sold $811 million worth of Tesla shares worthwhile purchasing $784.3 million, according to data compiled by the Korea Securities Depository.
It marked the first month since December 2019 in which there were more South Korean sellers than buyers of Tesla stock.
The trend continued in July with South Koreans selling Tesla shares amounting to $756.8 million, out sizing purchases of $716.1 million.
From Aug. 1 to 10, sales of Tesla stocks by South Koreans were equal to their purchases, both at $356.6 million.
South Koreans were also selling off Ark Innovation ETF, an exchange-traded fund product called popular for its 10 percent weighting in Tesla.
Since March, South Korean traders had divested $400 million worth of the flagship active ETF product from Ark Invest while purchasing just over $260 million during the same period.
South Korean investors purchased $430 million worth of Moderna stocks from July to Aug. 10, making it the fourth-largest US-listed stock after Tesla, Amazon, and Apple. Meanwhile, they sold $368 million worth of the said stock.
Consequently, Moderna’s stock price more than doubled over the last six months.
South Koreans also favored other vaccine stocks with Novavax and Pfizer making it in the top 50 list.
South Korean investors bought $32.1 billion worth of US-listed shares from June through Thursday while selling less than $30.4 billion.
